Screening for ovarian cancer has become an area of great interest because of the high mortality rate associated with advanced ovarian cancer. This article discusses the requirements for a test to be considered a screening modality, outlines the current methodology used in ovarian cancer screening, addresses the shortcomings as well as problems related to cost effectiveness with the current screening modalities, and identifies special circumstances in which ovarian cancer screening may be beneficial.